Odlo Kristin, Hentzen Jean, dit Chabert Jérémie Fournier, Ducki Sylvie, Gani Osman A B S M, Sylte Ingebrigt, Skrede Martina, Flørenes Vivi Ann, Hansen Trond Vidar
School of Pharmacy, Department of Pharmaceutical Chemistry, University of Oslo, PO Box 1068, N-0316 Oslo, Norway.
Bioorg Med Chem. 2008 May 1;16(9):4829-38. doi: 10.1016/j.bmc.2008.03.049. Epub 2008 Mar 23.
A series of cis-restricted 1,5-disubstituted 1,2,3-triazole analogues of combretastatin A-4 (1) have been prepared. The triazole 12f, 2-methoxy-5-(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-5-yl)aniline, displayed potent cytotoxic activity against several cancer cell lines with IC(50) values in the nanomolar range. The ability of triazoles to inhibit tubulin polymerization has been evaluated, and 12f inhibited tubulin polymerization with IC(50)=4.8microM. Molecular modeling experiments involving 12f and the colchicine binding site of alpha,beta-tubulin showed that the triazole moiety interacts with beta-tubulin via hydrogen bonding with several amino acids.
已制备了一系列康普他汀A-4(1)的顺式受限1,5-二取代1,2,3-三唑类似物。三唑化合物12f,即2-甲氧基-5-(1-(3,4,5-三甲氧基苯基)-1H-1,2,3-三唑-5-基)苯胺,对几种癌细胞系显示出强效细胞毒性活性,其IC(50)值在纳摩尔范围内。已评估了三唑类抑制微管蛋白聚合的能力,12f抑制微管蛋白聚合的IC(50)=4.8μM。涉及12f和α,β-微管蛋白的秋水仙碱结合位点的分子模拟实验表明,三唑部分通过与几个氨基酸形成氢键与β-微管蛋白相互作用。